The human body naturally makes a hormone called GLP-1, or Glucagon-Like Peptide-1. It helps signal fullness and stimulate insulin secretion in the body. GLP-1 drugs do something similar – but they ...

The imminent Indian patent expiry of Novo Nordisk’s global blockbuster anti-diabetic and weight loss treatment drug – the GLP ...

The birthday girl opted for a curve-clinging white dress that clung to her slender figure, fishnet stockings, glittering ruby ...

Final Apache AH-64E helicopters arrive in India, US calls it a 'milestone' in defence partnership $513bn vs $105bn: Why the ...

In this video, Mikhail Varshavski, DO, who goes by "Dr. Mike," talks with Christle Guevarra, DO, MS, about her struggle with weight, her journey with GLP-1 drugs, and her career in medicine.

Arizona lawmakers are considering recognizing obesity as a chronic disease and examining the cost savings of covering ...

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from ...

For the last installment of the America in Focus project this year, we spoke with 14 Americans from all walks of life who are ...

Eli Lilly ( LLY 1.19%) and Novo Nordisk ( NVO 2.44%) are two of the leading companies in the fast-growing GLP-1 weight loss ...

Judges allow consolidation of vision loss lawsuits filed against Novo Nordisk and Eli Lilly over diabetes and weight loss ...